申请人:THERAVANCE BIOPHARMA R&D IP, LLC
公开号:US20210154178A1
公开(公告)日:2021-05-27
The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.